SCHEDULE 13D/A Filed 2026-08-20 Event 2026-08-03 SEC 0001493152-26-039484 →

LoPriore Vincent S → Hepion Pharmaceuticals, Inc. CTRVP

Stake: — Shares: 21,000,000 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

12 transactions

12 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest

—

Not in latest FINRA snapshot

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-08-03	Stetz Gary S. II	director	Buy	500,000	$0.05	$25K
2026-08-03	Stetz Gary S. II	director	Buy	500,000	$0.06	$30K
2026-08-03	Stetz Gary S.	director, officer	Buy	2,000,000	$0.05	$100K
2026-08-03	Stetz Gary S.	director, officer	Buy	2,000,000	$0.06	$120K
2026-08-03	Purcell Michael J.	director	Buy	2,000,000	$0.05	$100K
2026-08-03	Purcell Michael J.	director	Buy	2,000,000	$0.06	$120K
2026-08-03	Appajosyula Sireesh	director, officer	Buy	2,000,000	$0.05	$100K
2026-08-03	Appajosyula Sireesh	director, officer	Buy	2,000,000	$0.06	$120K
2026-08-03	LoPriore Vincent S	director, officer	Buy	8,000,000	$0.05	$400K
2026-08-03	LoPriore Vincent S	director, officer	Buy	2,000,000	$0.05	$100K
2026-08-03	LoPriore Vincent S	director, officer	Buy	8,000,000	$0.06	$480K
2026-08-03	LoPriore Vincent S	director, officer	Buy	2,000,000	$0.06	$120K

Other 13D/G Filings on Hepion Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2026-08-20	SCHEDULE 13D	Stetz Gary S.	5.70%	5,250,000	view →
2026-08-20	SCHEDULE 13D	Appajosyula Sireesh	5.70%	5,250,000	view →
2026-08-07	SCHEDULE 13D	Black Global 5 LLC	11.10%	10,000,000	view →
2026-05-01	SCHEDULE 13D	LoPriore Vincent S	21.46%	5,000,000	view →

Other Filings by LoPriore Vincent S

Filed	Form	Issuer	Stake	Shares
2026-05-01	SCHEDULE 13D	Hepion Pharmaceuticals, Inc. CTRVP	21.46%	5,000,000	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →